Fig. 2 | Scientific Reports

Fig. 2

From: First-line treatment of EGFR-mutated non-small cell lung cancer with brain metastases: a systematic review and meta-analysis

Fig. 2

Network meta-analysis plots comparing therapies for (A) overall survival (OS), (B) progression-free survival (PFS), (C) intracranial PFS (iPFS), (D) intracranial objective response rate (iORR), and (E) intracranial disease control rate (iDCR) in EGFR-mutant NSCLC with brain metastases. Lines indicate individual head-to-head comparisons, with line thickness indicating the number of trials per comparison.

Back to article page